Hypopharyngeal cancer secondary prevention: Difference between revisions
(Mahshid) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
Secondary prevention measures of hypopharyngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively. | Secondary prevention measures of hypopharyngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Revision as of 20:11, 17 January 2019
|
Hypopharyngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypopharyngeal cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hypopharyngeal cancer secondary prevention |
|
Risk calculators and risk factors for Hypopharyngeal cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Secondary prevention measures of hypopharyngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.
Secondary Prevention
Follow up after treatment
Patients treated for hypopharyngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1]
| Follow up | Description |
|---|---|
|
|
|
|
|
|
|
|
|
|
References
- ↑ Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.